7th Trends in Head & Neck Oncology

thno2019.org

 

7th Trends in Head & Neck Oncology
A

Does p16/HPV Positivity Confer Survival Advantage in Non-Oropharyngeal Head & Neck Squamous Cell Cancer?

By 7th Trends in Head & Neck Oncology FEATURING Amanda Psyrri
By 7th Trends in Head & Neck Oncology FEATURING Amanda Psyrri
29 views
January 20, 2020
0 Comments
Login to view comments. Click here to Login
Primary Disease
26:53
7th Trends in Head & Neck Oncology

Navigation & Optical Imaging Are the Most Promising to Improve I…

Feat. P. Nicolai
20:15
7th Trends in Head & Neck Oncology

High-Dose Three-Weekly or Low-Dose Weekly Cisplatin During Radiation…

Feat. P. Szturz
24:13
7th Trends in Head & Neck Oncology

Where and When to Use the Induction Chemotherapy in Head & Neck …

Feat. J. Vermorken
17:18
7th Trends in Head & Neck Oncology

Does p16/HPV Positivity Confer Survival Advantage in Non-Oropharynge…

Feat. A. Psyrri
16:18
7th Trends in Head & Neck Oncology

Is There a Role for Neoadjuvant Targeted and Immunotherapies in Head…

Feat. J. Machiels